Current Therapeutic Strategies for Metastatic Triple-Negative Breast Cancer: From Pharmacists' Perspective.

J Clin Med · 2022 · PMC9604829 · PMID 36294342

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

As the same time, the combination of platinum and PARP inhibitor veliparib also significantly improved PFS and showed a trend towards improved OS for patients with mTNBC [ 19 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.